CARLOS AGUILAR: Open Payments
NPI 1477520484 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,138 in 28 payments from 12 companies in 2025. Trend: 2023 $1,576 · 2024 $936 · 2025 $3,138
Food & beverage: $3,138
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $551 |
| Amgen Inc. | 3 | $393 |
| Abbott Laboratories | 3 | $382 |
| Novo Nordisk Inc | 3 | $365 |
| GlaxoSmithKline, LLC. | 3 | $342 |
| ABBVIE INC. | 3 | $329 |
| Medtronic, Inc. | 1 | $203 |
| Stryker Corporation | 1 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $122 |
Products named: FREESTYLE LIBRE 3, REPATHA, TEZSPIRE, Wegovy, VRAYLAR, INTERSTIM, FARXIGA, FLOWTRIEVER CATHETER, S.
Industry payments across AZ — which companies pay providers there.
